Deadline for manuscript submissions: 09 June 2022Print Special Issue Flyer (11)
Director of the Center for Intensive Care and Anesthesiology of San Raffaele Scientific Institute and Associate Professor at Vita-Salute San Raffaele University, Milan, Italy
Interests: Intensive care and Anesthesia
Sex and gender differences are considered two emerging risk factors impacting morbidity and mortality. Sex, as the biological difference between men and women, influences physiology and pathophysiology of diseases. On the other hand, gender, as a social construct, may influence patient behaviour and clinician approach. Sex and gender disparities are reported in epidemiology, pathophysiology, clinical manifestations, and in response to treatment of diseases. They could be explained not only by genetic, epigenetic, and hormonal factors, but also by social behaviours such as smoking, alcohol, social attitude, sexual behaviour, and occupation.
The need for personalized medicine and patient-tailored treatment encourages physicians and researchers to consider sex and gender when dealing with disease prevention, diagnosis, and treatment. Cardiovascular diseases, cancer and metabolic syndrome, which are some of the most prevalent diseases worldwide, have been demonstrated to be strongly affected by sex and gender differences with a male prevalence. Instead, autoimmune diseases, pulmonary diseases, psychiatric and neurological diseases have a higher incidence in women compared to men.
However, evidence assessing sex and gender differences among peri-operative patients and critically ill patients hospitalized in the emergency department and in the intensive care unit are still lacking. Variations in response to treatment of critically ill patients, according to sex and gender, should be more deeply investigated. Therefore, our journal is keen on publishing a special issue on sex and gender differences in the following settings: out of hospital and in-hospital emergencies; management of critically ill patients outside and inside the intensive care units; and perioperative setting.
Sex and gender differences, Peri-operative patients, Critically ill patients, Emergency department, Intensive care unit
Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access journal published by MRE Press. As of January 2021, Signa Vitae will change to a bimonthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.
Online publish date: 10 March 2022
(This article belongs to the Special Issue Sex-related differences in peri-operative and in critically ill patients)
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.